Skip to main content
Signal8
Launch Terminal
Kasturi Vijay profile photo

Vijay Kasturi

CIK: 0002007109

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CG Oncology, Inc. logo
CGON

CG Oncology, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • CG Oncology, Inc. logo
    CGON

    CG Oncology, Inc.

    Apr 15, 2026
    Award(A)

    Employee Stock Option (Right to Buy)

    Direct
    79.2K shares-
  • CG Oncology, Inc. logo
    CGON

    CG Oncology, Inc.

    Apr 15, 2025
    Award(A)

    Employee Stock Option (Right to Buy)

    Direct
    203.9K shares-
  • CG Oncology, Inc. logo
    CGON

    CG Oncology, Inc.

    Oct 4, 2024
    Award(A)

    Stock Option (Right to Buy)

    Direct
    132.6K shares-

1-3 of 3

About Kasturi Vijay

Kasturi Vijay (SEC CIK 0002007109) files insider reports with the SEC as Chief Medical Officer of CG Oncology, Inc. (CGON).

Signal8 holds 3 ownership filings by Kasturi Vijay, all Form 4s, filed between Oct 7, 2024 and Apr 16, 2026. Those filings report 3 transactions, from Oct 4, 2024 to Apr 15, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Kasturi Vijay's filings is in DALLAS, TX.

Recent filings by Kasturi Vijay

  • Apr 15, 2026: Grant or award of CGON derivative securities (Form 4, code A).
  • Apr 15, 2025: Grant or award of CGON derivative securities (Form 4, code A).
  • Oct 4, 2024: Grant or award of CGON derivative securities (Form 4, code A).

Other insiders filing for CG Oncology, Inc. (CGON)

How to read Form 4 transaction codes